SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 28, 2018
GSRX INDUSTRIES INC.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
Building No. 3, P.E. 606, int. Jose Efron Ave.
Dorado, Puerto Rico 00646
(Address of principal executive offices) (zip code)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Darrin M. Ocasio, Esq.
Sichenzia Ross Ference LLP
1185 Avenue of the Americas, 37th Floor
New York, New York 10036
Phone: (212) 930-9700
Fax: (212) 930-9725
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|[ ]||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|[ ]||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|[ ]||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|[ ]||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Item 8.01 Other Events.
As previously disclosed, GSRX Industries Inc. (the “Company”) entered into a letter of intent dated September 18, 2018 (the “LOI”) with So-Cal MM Patients Association, LLC (the “Seller”), pursuant to which the Company would acquire and assume all of the assets of a cannabis dispensary business. On November 28, 2018, the Company terminated the LOI. No definitive agreements for any transaction contemplated by the LOI were entered into between the parties prior to the termination of the LOI.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|GSRX INDUSTRIES INC.|
|Dated: November 28, 2018||By:||/s/ Thomas Gingerich|
|Title:||Chief Financial Officer|